Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
9,743.95
9,152.57
7,905.21
7,840.80
5,545.52
5,975.78
5,806.35
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,743.95
9,152.57
7,905.21
7,840.80
5,545.52
5,975.78
5,806.35
Raw Material Cost
3,913.70
4,013.93
3,094.52
2,880.15
2,051.80
2,124.06
2,181.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
1,485.54
1,504.67
147.03
162.69
1,413.37
1,316.33
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
252.76
144.67
87.90
80.57
96.68
140.73
135.81
Selling and Distribution Expenses
3,719.94
3,301.86
2,877.83
2,853.96
2,337.36
2,676.95
2,514.00
Other Expenses
-25.28
-163.02
-159.26
-22.76
-25.94
-155.41
-145.21
Total Expenditure (Excl Depreciation)
7,633.64
7,315.79
5,972.35
5,734.11
4,389.16
4,801.00
4,695.04
Operating Profit (PBDIT) excl Other Income
2110.3
1836.8000000000002
1932.8999999999999
2106.7
1156.4
1174.8
1111.3
Other Income
-906.96
-1,135.34
-837.25
-616.02
-471.63
-459.39
-426.94
Operating Profit (PBDIT)
1,203.35
1,268.59
1,625.94
1,938.55
1,141.37
1,229.33
1,109.66
Interest
252.76
144.67
87.90
80.57
96.68
140.73
135.81
Exceptional Items
0.00
102.12
27.80
-32.92
5.41
0.00
0.00
Gross Profit (PBDT)
5,830.25
5,138.64
4,810.69
4,960.65
3,493.72
3,851.73
3,625.31
Depreciation
0.00
567.15
505.51
447.88
456.63
513.94
425.28
Profit Before Tax
950.58
658.89
1,060.32
1,377.19
593.47
574.66
548.56
Tax
201.49
205.07
408.65
279.38
96.08
108.57
172.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
663.54
417.19
571.83
982.32
560.35
403.27
321.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
663.54
417.19
571.83
982.32
560.35
403.27
321.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
85.55
36.62
79.84
127.20
39.91
63.82
54.55
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
749.09
453.81
651.67
1,109.53
600.26
467.09
376.32
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
11,127.71
8,103.12
7,771.85
7,547.85
6,627.90
5,905.83
5,143.06
Earnings per share (EPS)
0.0
11.49
16.73
28.41
16.21
11.66
9.31
Diluted Earnings per share
0.0
11.49
16.73
28.41
16.21
11.66
9.31
Operating Profit Margin (Excl OI)
21.66%
20.07%
24.76%
26.87%
20.85%
19.66%
19.14%
Gross Profit Margin
9.76%
13.4%
19.81%
23.28%
18.94%
18.22%
16.77%
PAT Margin
6.81%
4.56%
7.23%
12.53%
10.1%
6.75%
5.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.46% vs 15.78% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 65.07% vs -30.37% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -12.21% vs -2.41% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 74.71% vs 64.62% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Ceylon Hospitals Plc With
Figures in Million
Consolidate Annual Results
Change(LKR)
Change(%)
Net Sales
9,743.95
0
9,743.95
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,743.95
0
9,743.95
Raw Material Cost
3,913.70
0
3,913.70
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
252.76
0
252.76
Selling and Distribution Expenses
3,719.94
0
3,719.94
Other Expenses
-25.28
0.00
-25.28
Total Expenditure (Excl Depreciation)
7,633.64
0
7,633.64
Operating Profit (PBDIT) excl Other Income
2,110.30
0.00
2,110.30
Other Income
-906.96
0
-906.96
Operating Profit (PBDIT)
1,203.35
0
1,203.35
Interest
252.76
0
252.76
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
5,830.25
0
5,830.25
Depreciation
0.00
0
0.00
Profit Before Tax
950.58
0
950.58
Tax
201.49
0
201.49
Provisions and contingencies
0
0
0.00
Profit After Tax
663.54
0
663.54
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
663.54
0
663.54
Share in Profit of Associates
0
0
0.00
Minority Interest
85.55
0
85.55
Other related items
0.00
0.00
0.00
Consolidated Net Profit
749.09
0
749.09
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
11,127.71
0
11,127.71
Earnings per share (EPS)
0.00
0
0.00
Diluted Earnings per share
0.00
0
0.00
Operating Profit Margin (Excl OI)
21.66%
0%
0.00
21.66%
Gross Profit Margin
9.76%
0%
0.00
9.76%
PAT Margin
6.81%
0%
0.00
6.81%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 974.39 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 6.46% vs 15.78% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 74.91 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 65.07% vs -30.37% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 211.03 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -12.21% vs -2.41% in Mar 2024
Annual - Interest
Interest 25.28 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 74.71% vs 64.62% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.66%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






